CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | 12 Months Ended |
Sep. 30, 2024 | Mar. 31, 2024 | Sep. 30, 2023 | Mar. 31, 2023 | Sep. 30, 2024 | Sep. 30, 2023 | Dec. 31, 2023 |
Operating activities: | | | | | | | |
Net income | $ 96,840 | $ 88,905 | $ 63,736 | $ 112,246 | $ 255,870 | $ 232,390 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | |
Depreciation and amortization | | | | | 278,065 | 272,807 | |
Accretion of debt premium and discount, net | | | | | (2,148) | (2,198) | |
Deferred financing cost amortization | | | | | 5,369 | 5,163 | |
Accretion of above- and below-market leases, net | | | | | (7,271) | (9,361) | |
Tenant inducement amortization and other | | | | | 1,937 | 3,205 | |
Impairment of real estate assets | 5,863 | | | | 11,143 | 17,836 | |
Gain on sale of real estate assets | | | | | (53,974) | (59,037) | |
Equity based compensation | | | | | 13,855 | 14,559 | |
Gain on extinguishment of debt, net | | | | | (554) | (4,356) | |
Changes in operating assets and liabilities: | | | | | | | |
Receivables, net | | | | | 13,671 | (937) | |
Deferred charges and prepaid expenses | | | | | (30,780) | (37,619) | |
Other assets | | | | | (642) | (760) | |
Accounts payable, accrued expenses and other liabilities | | | | | (15,027) | 21,820 | |
Net cash provided by operating activities | | | | | 469,514 | 453,512 | |
Investing activities: | | | | | | | |
Improvements to and investments in real estate assets | | | | | (255,423) | (254,426) | |
Acquisitions of real estate assets | | | | | (81,862) | (1,914) | |
Proceeds from sales of real estate assets | | | | | 141,901 | 162,194 | |
Purchase of marketable securities | | | | | (26,064) | (20,442) | |
Proceeds from sale of marketable securities | | | | | 25,264 | 21,566 | |
Net cash used in investing activities | | | | | (196,184) | (93,022) | |
Financing activities: | | | | | | | |
Repayment of borrowings under unsecured revolving credit facility | | | | | (98,500) | (480,000) | |
Proceeds from borrowings under unsecured revolving credit facility | | | | | 80,000 | 360,000 | |
Proceeds from unsecured notes and term loans | | | | | 796,152 | 200,000 | |
Repayment of borrowings under unsecured notes | | | | | (367,449) | (194,254) | |
Deferred financing and debt extinguishment costs | | | | | (7,714) | (700) | |
Proceeds from issuances of common shares | | | | | 19,280 | 0 | |
Distributions to common stockholders | | | | | (248,576) | (236,881) | |
Repurchases of common shares in conjunction with equity award plans | | | | | (12,980) | (11,231) | |
Net cash provided by (used in) financing activities | | | | | 160,213 | (363,066) | |
Net change in cash, cash equivalents and restricted cash | | | | | 433,543 | (2,576) | |
Cash, cash equivalents and restricted cash at beginning of period | | 18,904 | | 21,259 | 18,904 | 21,259 | $ 21,259 |
Cash, cash equivalents and restricted cash at end of period | 452,447 | | 18,683 | | 452,447 | 18,683 | 18,904 |
Reconciliation to consolidated balance sheets: | | | | | | | |
Cash and cash equivalents | 451,326 | | 861 | | 451,326 | 861 | 866 |
Restricted cash | 1,121 | | 17,822 | | 1,121 | 17,822 | 18,038 |
Cash, cash equivalents and restricted cash at end of period | 452,447 | | 18,683 | | 452,447 | 18,683 | 18,904 |
Supplemental disclosure of cash flow information: | | | | | | | |
Cash paid for interest, net of amount capitalized of $2,887 and $2,987 | | | | | 151,862 | 144,271 | |
Brixmor Operating Partnership LP | | | | | | | |
Operating activities: | | | | | | | |
Net income | 96,840 | 88,905 | 63,736 | 112,246 | 255,870 | 232,390 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | |
Depreciation and amortization | | | | | 278,065 | 272,807 | |
Accretion of debt premium and discount, net | | | | | (2,148) | (2,198) | |
Deferred financing cost amortization | | | | | 5,369 | 5,163 | |
Accretion of above- and below-market leases, net | | | | | (7,271) | (9,361) | |
Tenant inducement amortization and other | | | | | 1,937 | 3,205 | |
Impairment of real estate assets | | | | | 11,143 | 17,836 | |
Gain on sale of real estate assets | | | | | (53,974) | (59,037) | |
Equity based compensation | | | | | 13,855 | 14,559 | |
Gain on extinguishment of debt, net | | | | | (554) | (4,356) | |
Changes in operating assets and liabilities: | | | | | | | |
Receivables, net | | | | | 13,671 | (937) | |
Deferred charges and prepaid expenses | | | | | (30,780) | (37,619) | |
Other assets | | | | | (642) | (760) | |
Accounts payable, accrued expenses and other liabilities | | | | | (15,027) | 21,820 | |
Net cash provided by operating activities | | | | | 469,514 | 453,512 | |
Investing activities: | | | | | | | |
Improvements to and investments in real estate assets | | | | | (255,423) | (254,426) | |
Acquisitions of real estate assets | | | | | (81,862) | (1,914) | |
Proceeds from sales of real estate assets | | | | | 141,901 | 162,194 | |
Purchase of marketable securities | | | | | (26,064) | (20,442) | |
Proceeds from sale of marketable securities | | | | | 25,264 | 21,566 | |
Net cash used in investing activities | | | | | (196,184) | (93,022) | |
Financing activities: | | | | | | | |
Repayment of borrowings under unsecured revolving credit facility | | | | | (98,500) | (480,000) | |
Proceeds from borrowings under unsecured revolving credit facility | | | | | 80,000 | 360,000 | |
Proceeds from unsecured notes and term loans | | | | | 796,152 | 200,000 | |
Repayment of borrowings under unsecured notes | | | | | (367,449) | (194,254) | |
Deferred financing and debt extinguishment costs | | | | | (7,714) | (700) | |
Proceeds from issuances of common shares | | | | | 19,280 | 0 | |
Partner distributions and repurchases of OP Units | | | | | (262,216) | (247,185) | |
Net cash provided by (used in) financing activities | | | | | 159,553 | (362,139) | |
Net change in cash, cash equivalents and restricted cash | | | | | 432,883 | (1,649) | |
Cash, cash equivalents and restricted cash at beginning of period | | $ 18,904 | | $ 20,332 | 18,904 | 20,332 | 20,332 |
Cash, cash equivalents and restricted cash at end of period | 451,787 | | 18,683 | | 451,787 | 18,683 | 18,904 |
Reconciliation to consolidated balance sheets: | | | | | | | |
Cash and cash equivalents | 450,666 | | 861 | | 450,666 | 861 | 866 |
Restricted cash | 1,121 | | 17,822 | | 1,121 | 17,822 | 18,038 |
Cash, cash equivalents and restricted cash at end of period | $ 451,787 | | $ 18,683 | | 451,787 | 18,683 | $ 18,904 |
Supplemental disclosure of cash flow information: | | | | | | | |
Cash paid for interest, net of amount capitalized of $2,887 and $2,987 | | | | | $ 151,862 | $ 144,271 | |